Breast Cancer Coverage from Every Angle
Advertisement
Advertisement

Recent News

ASCO 2019: Final Results of KRISTINE Trial of Neoadjuvant Regimens in HER2-Positive Breast Cancer
New Trastuzumab Biosimilar Approved by the FDA
ASCO 2019: Can Clinical Risk Stratification Predict Chemotherapy Benefit in Early Breast Cancer?
Targeting Mitochondrial Metabolism in Triple-Negative Breast Cancer
ACP Issues New Guidance Statement for Breast Cancer Screening in Average-Risk Women
ASCO 2019: CDK4/6 Inhibitor Plus Endocrine Therapy Improves Overall Survival in Advanced Breast Cancer
Retrospective Update on Nipple-Sparing Mastectomy
U.S. and Canadian Home Recovery Programs After Mastectomy
FDA Approves Alpelisib Combination Therapy for Advanced Breast Cancer
Breast Cancer Treatment Outcomes in Young Women
Effect of Chemotherapy Scheduling on Quality of Life in Advanced Breast Cancer
ARRS 2019: BI-RADS 3 Lesions Identified on High-Risk Screening Breast MRI
ASCO 2019: Can a Low-Fat Diet Reduce Breast Cancer Mortality?
Leronlimab Granted Fast Track Designation in Metastatic Triple-Negative Breast Cancer
ESMO Breast 2019: Global Survey of HER2 Testing Shows Room for Improvement
ESMO Breast 2019: Intermittent vs. Continuous Chemotherapy in HER2-Negative Breast Cancer
ASBrS 2019: Some Women With HER2-Positive Breast Cancer May Not Need Surgery
Ado-Trastuzumab Emtansine Granted FDA Approval in HER2-Positive Early Breast Cancer
ESMO Breast 2019: De-escalation Strategy for Women With HER2-Positive Metastatic Breast Cancer
ESTRO 2019: 10-Year Follow-up of Whole-Breast Irradiation in Low-Risk Breast Cancer
Breast Cancer’s Genetic Relationship to Other Cancers
Brain Metastases and Estrogen: Is There a Link in Triple-Negative Breast Cancer?
Canada Halts Sales of Cancer-Linked Breast Implants
INT230-6 Granted Fast Track Designation in Metastatic Triple-Negative Breast Cancer
AACR 2019: Primary Tumor Surgery for Advanced HER2-Positive Breast Cancer
AACR 2019: Predicting Breast Cancer Survival With Estrogen Byproducts
HOPA 2019: Does Receptor Expression Affect Efficacy of Talazoparib in Advanced Breast Cancer?
Is There a Link Between Age Acceleration and Breast Cancer Risk?
FDA Extends Indication of Palbociclib Combination to Men With Breast Cancer
Novel Antibody Drug-Conjugate in Metastatic Triple-Negative Breast Cancer
Study Finds Shifting Trend in Breast Cancer Risk in Asian American Women
Predicting Outcomes With Lung Immune Prognostic Index
ASCO-SITC 2019: HER2-Targeted Vaccine Plus Trastuzumab in Breast Cancer
Trastuzumab Biosimilar for HER2-Overexpressing Breast Cancer Approved by the FDA
FDA Grants Accelerated Approval to Atezolizumab Combination in Triple-Negative Breast Cancer
FDA Approves New Formulation of Trastuzumab for Subcutaneous Use in Some Breast Cancers
2019 ASCO-SITC: Neoadjuvant Chemotherapy and the Immunologic Landscape in Breast Cancer
Targeting Chemotherapy-Resistant Breast Cancer
Can Oolong Tea Inhibit Growth of Breast Cancer?
Reducing Risk for Invasive Breast Cancer With Low-Dose Tamoxifen
Comparing Breast Irradiation Regimens in Preventing Local Recurrence
Impact of Pathologic Complete Response on Breast Cancer Recurrence and Mortality
Racial Disparities in Breast Cancer Prevention: Focus on Complexity of Gathering Information
FDA Approves Trastuzumab Biosimilar for Treatment of Advanced Breast Cancer
Predictive Biomarker in Metastatic Triple-Negative Breast Cancer
Does Oxybutynin Reduce Hot Flashes in Breast Cancer Survivors?
SOLAR-1: Predicting Response to Alpelisib in PIK3CA-Mutant Breast Cancer
Can Cryoablation ‘Freeze Out’ Low-Risk Breast Cancers?
Shedding Light on Resistance to PARP Inhibitors in Patients With Breast Cancer
Conventional Whole-Breast vs. Partial-Breast Irradiation in Controlling Tumor Recurrence
Should Some Women Younger Than Age 30 Undergo Mammography?


By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.